RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 158 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,304,978 | +160.9% | 954,899 | +154.7% | 0.00% | – |
| Q2 2023 | $2,800,211 | +35.7% | 374,861 | +21.1% | 0.00% | – |
| Q1 2023 | $2,064,013 | +154276.4% | 309,514 | +78.6% | 0.00% | – |
| Q4 2022 | $1,337 | -99.9% | 173,336 | -4.3% | 0.00% | – |
| Q3 2022 | $1,927,000 | +39.7% | 181,138 | +7.0% | 0.00% | – |
| Q2 2022 | $1,379,000 | +51.5% | 169,350 | +33.3% | 0.00% | – |
| Q1 2022 | $910,000 | -66.0% | 127,039 | -18.8% | 0.00% | – |
| Q4 2021 | $2,679,000 | +268.5% | 156,429 | +395.0% | 0.00% | – |
| Q3 2021 | $727,000 | -0.4% | 31,603 | +58.1% | 0.00% | – |
| Q2 2021 | $730,000 | – | 19,992 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Data Collective IV GP, LLC | 5,941,120 | $45,806,035 | 48.11% |
| Kinnevik AB (publ) | 7,653,061 | $59,005,100 | 33.28% |
| MV Management XI, L.L.C. | 1,971,908 | $15,203,411 | 26.45% |
| MIC Capital Management UK LLP | 8,451,758 | $65,163,057 | 12.86% |
| ArchPoint Investors | 1,114,626 | $8,593,766 | 4.07% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $11,636,348 | 1.44% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,710,339 | $20,896,714 | 0.80% |
| Duquesne Family Office | 1,385,950 | $10,685,675 | 0.53% |
| ALLEN OPERATIONS LLC | 217,657 | $1,678,135 | 0.45% |
| Artal Group S.A. | 960,204 | $7,403 | 0.41% |